Skip to content
Open access

Vaccination targeting the novel endogenous tumor-associated antigen Gpr149 induces protective immunity against checkpoint inhibitor-refractory SB28 glioblastoma

Oct 2026 · bioRxiv · 0 citations
Biology Medicine
Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.